← Back to Search

Re-Connect App for Smoking Cessation

N/A
Recruiting
Led By Bethany Raiff, PhD
Research Sponsored by Rowan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals who report smoking at least 10 cigarettes per day for at least 2 years and are 18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

Study Summary

This trial will test if making people use an app to prove they're not smoking works to help them quit.

Who is the study for?
This trial is for adults who have smoked at least 10 cigarettes daily for over 2 years, want to quit smoking (strong desire), can use a smartphone, and speak English. They must not have health issues like severe lung conditions or unmanaged mental health problems.Check my eligibility
What is being tested?
The study tests two methods using smartphone apps that reward quitting smoking: one restricts app access unless you prove you're smoke-free, while the other rewards abstinence with more app features.See study design
What are the potential side effects?
There are no direct medical side effects since this trial involves behavior modification through technology rather than medication. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have smoked 10 cigarettes daily for 2+ years and am 18 or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7-day point prevalence of self-reported, and CO verified, smoking
Acceptability (RCT, Aim 2)
Duration of Re-Connect Use (RCT, Aim 2)
+3 more
Secondary outcome measures
Initial Acceptability
Other outcome measures
Smartphone Use Moderators

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Abstinent Contingent (AC) Re-ConnectExperimental Treatment1 Intervention
Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO<=6ppm).
Group II: Submission Contingent (SC) Re-ConnectActive Control1 Intervention
Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Find a Location

Who is running the clinical trial?

Rowan UniversityLead Sponsor
23 Previous Clinical Trials
2,783 Total Patients Enrolled
University of KentuckyOTHER
186 Previous Clinical Trials
226,602 Total Patients Enrolled
Bethany Raiff, PhDPrincipal InvestigatorRowan University
1 Previous Clinical Trials
52 Total Patients Enrolled

Media Library

Abstinent Contingent (AC) Re-Connect Clinical Trial Eligibility Overview. Trial Name: NCT05224154 — N/A
Acceptability of Health Care Research Study Groups: Submission Contingent (SC) Re-Connect, Abstinent Contingent (AC) Re-Connect
Acceptability of Health Care Clinical Trial 2023: Abstinent Contingent (AC) Re-Connect Highlights & Side Effects. Trial Name: NCT05224154 — N/A
Abstinent Contingent (AC) Re-Connect 2023 Treatment Timeline for Medical Study. Trial Name: NCT05224154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is this research endeavor accommodating?

"Affirmative. According to the clinicaltrials.gov website, this medical research began seeking candidates on December 14th 2021 and was last edited on February 4th 2022. 82 patients need to be recruited from one location for successful completion of the trial."

Answered by AI

Are there any opportunities for participation in this trial currently available?

"Affirmative. Data found on clinicaltrials.gov affirms that this trial, initially posted on December 14th 2021, is currently seeking out participants. The research requires 82 individuals to enroll across a single site."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
What site did they apply to?
Rowan University
What portion of applicants met pre-screening criteria?
Met criteria
~23 spots leftby Mar 2025